- Report
- May 2025
- 164 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2025
- 105 Pages
Europe
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2025
- 100 Pages
India
From €4257EUR$4,750USD£3,652GBP
- Report
- September 2024
- 140 Pages
Asia Pacific
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 179 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 113 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 102 Pages
India
From €4257EUR$4,750USD£3,652GBP
- Report
- February 2024
- 115 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- August 2022
- 111 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- December 2024
- 150 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- June 2026
- 75 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- November 2024
- 65 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- August 2024
- 53 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- December 2023
- 63 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- June 2021
- 55 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- December 2024
- 150 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- July 2025
- 295 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- May 2025
- 148 Pages
India
From €2241EUR$2,500USD£1,922GBP
- Report
- January 2025
- 157 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- April 2025
- 142 Pages
Italy
From €2241EUR$2,500USD£1,922GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more